Trial results
AI generated results summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
According to the results reported on ClinicalTrials.gov, this trial involved six people in a single group, all of whom received a treatment called HPPH (a type of light-sensitive drug used in photodynamic therapy, where a drug is activated by light to target tumour cells). Five participants completed the trial, while one did not finish. The trial was set up to measure how tumours responded to the treatment, as well as a range of secondary measures including symptom relief, how much of the drug concentrated in the tumour, and certain biological changes in tumour cells detected through laboratory tests. The reported data shows that while the trial did record these outcome measures — including tumour response, symptom changes using something called the Pulmonary Symptom Scale, drug concentration in tumour tissue, and laboratory markers of cell activity — no numerical results were included in the data submitted to ClinicalTrials.gov for any of these outcomes. In other words, the specific numbers that would normally describe what was found have not been reported in the structured results section of the registry. Because no measurement data was provided for any of the primary or secondary outcomes, it is not possible to describe what the trial found in numerical terms. These are the results as reported to ClinicalTrials.gov. They are not medical advice — always discuss what they mean for you with your doctor.
These are the results as reported to ClinicalTrials.gov, not medical advice. Verify independently with the trial site and discuss what they mean for you with your doctor.
Phase 2 Lung Cancer Trial, Terminated
voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice
Who may and may not be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who may be able to join
- You have been diagnosed with advanced non-small cell lung cancer that is blocking an airway, confirmed by a tissue sample (biopsy)
- Your cancer type is squamous cell carcinoma, adenocarcinoma, or large cell carcinoma
- You are not able to have surgery, or you have chosen not to have surgery
- Your cancer has come back in the airway after previous surgery, radiation, or chemotherapy
- You are well enough to carry out some daily activities (your doctor will assess your general health level)
- Your blood cell counts, liver, and kidney function are within acceptable ranges (your doctor will check these)
- Your blood clotting ability is within an acceptable range
- You have had any previous cancer treatments, as long as chemotherapy or radiation finished at least 4 weeks before joining the trial
- You are not pregnant or breastfeeding, and if you could become pregnant, you have had a negative pregnancy test
Who may not be able to join
Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.
- Your scans show the tumor is wrapping around major blood vessels in the lungs
- You have a complete blockage of the upper airway and need emergency treatment to open it right away
- You have a known sensitivity or allergic reaction to porphyrin or similar compounds, or a condition called porphyria
- You have severe chronic obstructive pulmonary disease (a serious long-term lung condition) that would make it unsafe to have multiple bronchoscopies (a procedure to look inside the airways)
- You have a partial blockage of a central airway caused by mucus or debris build-up
- You have a severe blockage at the top of your windpipe (trachea)
- You are currently receiving chemotherapy or radiation therapy
- You have any condition that makes a bronchoscopy (airway examination procedure) unsafe for you
- You have underlying lung disease that means your lungs may not cope well with mucus or debris that can form after treatment (the lead doctor on the trial will assess this)
- You are pregnant or breastfeeding
- You are able to have children and are unwilling to use effective contraception during the trial and for 3 months after treatment ends
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial was run
These are the locations recorded on the registry, and they are a historical record: this trial is not enrolling, so they are not places you can join it.
Primary endpoints
Tumor Response
Other options
Data last synced from ClinicalTrials.gov: 2 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.